Benzinga's Microcap Movers for Tuesday July 17, 2012
Below are highlights from Benzinga's daily coverage of small cap and microcap securities making big moves:
Shares of Anthera Pharmaceuticals (NASDAQ: ANTH), the Hayward, CA biopharmaceutical company, rose another 20.30% Tuesday on 16 times average volume.
Anthera Pharmaceuticals received positive comments from Summer Street Tuesday. The company rates Anthera a Buy with a $5.00 price target. On Monday, Anthera announced the final set of clinical data from the Phase 2b PEARL-SC study in patients with systemic lupus erythematosus.
Anthera Pharmaceuticals closed at $1.60 on Tuesday.
Riverdale Oil and Gas
Riverdale Oil and Gas (RVDO), the Austin, TX oil and gas development company, rose 133% Tuesday on 76 times average volume.
A spokesperson for Riverdale told Benzinga the move was most likely due to reports that two of the company's three oil and gas projects in Texas are producing now and the third should be in production soon. Riverdale holds an interest in the three projects, which are operated by Property Development Group.
Riverdale Oil and Gas closed at $0.07 on Tuesday.
Shares of Fuel Tech (NASDAQ: FTEK), the Warrenville, IL air pollution control company, rose 17.94% Tuesday on 3 times average volume.
Fuel Tech announced Tuesday it was awarded the largest air pollution control contract in its history. The $36.6 million order, placed by E.CL S.A., a major utility in Chile, includes turnkey installation of Low NOx Burners and Over-Fire Air systems and mill modernization for six coal-fired units. Equipment deliveries are scheduled to commence during the first quarter of 2013, with project completion occurring during the third quarter of 2014.
Fuel Tech closed at $5.39 on Tuesday.
The information in this article is taken from public sources, press releases, and websites that cannot always be verified. Please note that investing in microcap stocks is highly speculative. The companies mentioned here are for information purposes only. Benzinga makes no claim as to the suitability of these stocks as an investment. Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.